PAPER Urano Y, Ochiai S, Noguchi N
SEARCH RESULTS
330029 RESULTS
PAPER Klohs J, Politano IW, Deistung A, Grandjean J, Drewek A, Dominietto M, Keist R, Schweser F, Reichenbach JR, Nitsch RM, Knuesel I, Rudin M
Longitudinal Assessment of Amyloid Pathology in Transgenic ArcAβ Mice Using Multi-Parametric Magnetic Resonance Imaging.
PLoS One. 2013;8(6):e66097. PubMed: 23840405PAPER Schraml F, Chen K, Ayutyanont N, Auttawut R, Langbaum JB, Lee W, Liu X, Bandy D, Reeder SQ, Alexander GE, Caselli RJ, Fleisher AS, Reiman EM,
Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose.
PLoS One. 2013;8(6):e67163. PubMed: 23840615PAPER Müller HP, Kassubek J, Vernikouskaya I, Ludolph AC, Stiller D, Rasche V
Diffusion tensor magnetic resonance imaging of the brain in APP transgenic mice: a cohort study.
PLoS One. 2013;8(6):e67630. PubMed: 23840754PAPER Bhullar KS, Rupasinghe HP
Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.
Oxid Med Cell Longev. 2013;2013:891748. PubMed: 23840922PAPER Enciu AM, Popescu BO
Is there a causal link between inflammation and dementia?
Biomed Res Int. 2013;2013:316495. PubMed: 23841061PAPER
Upcoming meetings related to Alzheimer's disease.
J Biomed Sci. 2013;20:33. PubMed: 23838167PAPER Stumm C, Hiebel C, Hanstein R, Purrio M, Nagel H, Conrad A, Lutz B, Behl C, Clement AB
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
Neurobiol Aging. 2013 Nov;34(11):2574-84. PubMed: 23838176PAPER Josephs KA, Papenfuss SM, Duffy JR, Strand EA, Machulda MM, Whitwell JL, Petersen RC
Occupational differences between Alzheimer's and aphasic dementias: implication for teachers.
Am J Alzheimers Dis Other Demen. 2013 Sep;28(6):612-6. PubMed: 23838322PAPER Samadi A, de la Fuente Revenga M, Pérez C, Iriepa I, Moraleda I, Rodríguez-Franco MI, Marco-Contelles J
Synthesis, pharmacological assessment, and molecular modeling of 6-chloro-pyridonepezils: New dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease.
Eur J Med Chem. 2013 Sep;67:64-74. PubMed: 23838422PAPER Haller S, Garibotto V, Kövari E, Bouras C, Xekardaki A, Rodriguez C, Lazarczyk MJ, Giannakopoulos P, Lovblad KO
Neuroimaging of dementia in 2013: what radiologists need to know.
Eur Radiol. 2013 Jul 10; PubMed: 23839168PAPER Pooler AM, Polydoro M, Wegmann SK, Pitstick R, Kay KR, Sanchez L, Carlson GA, Gomez-Isla T, Albers MW, Spires-Jones TL, Hyman BT
Tau- amyloid interactions in the rTgTauEC model of early Alzheimer's disease suggest amyloid induced disruption of axonal projections and exacerbated axonal pathology.
J Comp Neurol. 2013 Jul 10; PubMed: 23839581PAPER Ana S, Eelinor C, Van Hoesen GW, Lennart H, Ahmed S, Frithjof K, Mastrianni J
In vivo parahippocampal white matter pathology as a biomarker of disease progression to alzheimer disease.
J Comp Neurol. 2013 Jul 10; PubMed: 23839862PAPER Mura T, Proust-Lima C, Jacqmin-Gadda H, Akbaraly TN, Touchon J, Dubois B, Berr C
Measuring cognitive change in subjects with prodromal Alzheimer's disease.
J Neurol Neurosurg Psychiatry. 2013 Jul 9; PubMed: 23840054PAPER García-Escudero V, Martín-Maestro P, Perry G, Avila J
Deconstructing mitochondrial dysfunction in Alzheimer disease.
Oxid Med Cell Longev. 2013;2013:162152. PubMed: 23840916Current Filters
No filters selected